Search

What do systematic reviews say?

9 questions · 9 findings · 4 reviews · Schizophrenia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 9 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

PERPHENAZINE vs antipsychotics

Economic outcome ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Perphenazine for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

PERPHENAZINE vs placebo

Economic outcome ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Perphenazine for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pericyazine vs atypical antipsychotics

Economic outcome ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pericyazine vs Typical antipsychotics

Economic outcome ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Pericyazine for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FLUPENTHIXOL DECANOATE vs other depot antipsychotic drugs

Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FLUPENTHIXOL DECANOATE HIGH DOSE vs FLUPENTHIXOL DECANOATE STANDARD DOSE (˜40 mg/IM)

Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM)

Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FLUPENTHIXOL DECANOATE vs GENERAL ORAL ANTIPSYCHOTICS

Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

BRIEF FAMILY INTERVENTION vs usual care

Economic outcomes ‐ costs of care ‐ long term ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Family intervention (brief) for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found